Cargando…

Evaluation of the effect of chenodeoxycholic acid treatment on skeletal system findings in patients with cerebrotendinous xanthomatosis

AIM: The primary purpose of the present study is to evaluate the effect of chenodeoxycholic acid treatment on skeletal system findings in patients with cerebrotendinous xanthomatosis. MATERIAL AND METHODS: This retrospective study was conducted between June 2013 and December 2018 with seven patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zübarioğlu, Tanyel, Bilen, İnci Pınar, Kıykım, Ertugrul, Doğan, Beyza Belde, Enver, Ece Öge, Cansever, Mehmet Şerif, Zeybek, Ayşe Çiğdem Aktuğlu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666357/ https://www.ncbi.nlm.nih.gov/pubmed/31384146 http://dx.doi.org/10.14744/TurkPediatriArs.2019.23281

Ejemplares similares

Evaluation of clinical, neuroradiologic, and genotypic features of patients with L-2-hydroxyglutaric aciduria
por: Zübarioğlu, Tanyel, et al.
Publicado: (2020)

Maternal Inborn Errors of Metabolism Detected in Expanded Newborn Metabolic Screening
por: Tin, Oğuzhan, et al.
Publicado: (2023)

Long-term N-carbamylglutamate treatment of hyperammonemia in patients with classic organic acidemias
por: Kiykim, Ertugrul, et al.
Publicado: (2021)

Evaluation of plasma carnitine status in patients diagnosed with juvenile idiopathic arthritis
por: AKTUĞLU ZEYBEK, Ayşe Ciğdem, et al.
Publicado: (2022)

A Methionine-Portioning-Based Medical Nutrition Therapy with Relaxed Fruit and Vegetable Consumption in Patients with Pyridoxine-Nonresponsive Cystathionine-β-Synthase Deficiency
por: Uygur, Esma, et al.
Publicado: (2023)

Analysis of Biotinidase Activity in Serum by Digital Imaging Colorimetry Detection
por: Destanoğlu, Orhan, et al.
Publicado: (2023)

Clinical and neuroradiological approach to fucosidosis in a child with atypical presentation
por: Zubarioglu, Tanyel, et al.
Publicado: (2015)

An Overview of Acute Hepatic Porphyrias: Clinical Implications, Diagnostic Approaches, and Management Strategies
por: Zübarioğlu, Tanyel, et al.
Publicado: (2023)

Cerebrotendinous xanthomatosis‐associated diarrhea and response to chenodeoxycholic acid treatment
por: Brass, Eric P., et al.
Publicado: (2020)

Cerebrotendinous Xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid
por: Islam, Mahjabin, et al.
Publicado: (2021)

BNT162b2 COVID-19 vaccination elicited protective robust immune responses in pediatric patients with inborn errors of metabolism
por: Zubarioglu, Tanyel, et al.
Publicado: (2023)

Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment
por: Huidekoper, Hidde H., et al.
Publicado: (2015)

Case Report: Early Treatment With Chenodeoxycholic Acid in Cerebrotendinous Xanthomatosis Presenting as Neonatal Cholestasis
por: Degrassi, Irene, et al.
Publicado: (2020)

Cerebrotendinous xanthomatosis
por: Vadapalli, Satyadev
Publicado: (2013)

Cerebrotendinous xanthomatosis
por: Muniaswamy, Mahalakshmi, et al.
Publicado: (2016)

The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies
por: Verrips, Aad, et al.
Publicado: (2019)

Product development and quality of pharmacy compounded chenodeoxycholic acid capsules for Dutch cerebrotendinous xanthomatosis patients
por: Bouwhuis, Natalja, et al.
Publicado: (2023)

Case Report: Cerebrotendinous xanthomatosis
por: Karandikar, Amit A, et al.
Publicado: (2009)

Psychiatric manifestations in cerebrotendinous xanthomatosis
por: Fraidakis, M J
Publicado: (2013)

Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study
por: Stelten, Bianca M. L., et al.
Publicado: (2021)

A Preventable Ataxia: Cerebrotendinous Xanthomatosis
por: Shaji, Bhagya, et al.
Publicado: (2019)

Cerebrotendinous xanthomatosis - A case report
por: Parry, Arshed Hussain, et al.
Publicado: (2019)

Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

Screening of free carnitine and acyl-carnitine status in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

Cerebrotendinous Xanthomatosis with Nodular-hypertrophy of the Lumbosacral Roots
por: Hashimoto, Tomoyo, et al.
Publicado: (2018)

Cerebrotendinous xanthomatosis: A report of 3 cases
por: Saussy, Katharine, et al.
Publicado: (2020)

Cerebrotendinous xanthomatosis and infertility: A case report
por: Karimi, Narges, et al.
Publicado: (2022)

Allelic prevalence and geographic distribution of cerebrotendinous xanthomatosis
por: Pramparo, Tiziano, et al.
Publicado: (2023)

Using fiber tractography and diffusion kurtosis imaging to evaluate neuroimaging changes in patients with cerebrotendinous xanthomatosis after stopping chenodeoxycholic acid treatment for three years
por: Lee, Jun-Jun, et al.
Publicado: (2022)

Chenodeoxycholic acid rescues axonal degeneration in induced pluripotent stem cell-derived neurons from spastic paraplegia type 5 and cerebrotendinous xanthomatosis patients
por: Mou, Yongchao, et al.
Publicado: (2023)

Neuromuscular abnormality and autonomic dysfunction in patients with cerebrotendinous xanthomatosis
por: Chen, Shu-Fang, et al.
Publicado: (2011)

Clinical and genetic characteristics of Chinese patients with cerebrotendinous xanthomatosis
por: Tao, Qing-Qing, et al.
Publicado: (2019)

Cerebrotendinous xanthomatosis: a treatable hereditary neuro‐metabolic disease
por: de Cerqueira, Ana Claudia Rodrigues, et al.
Publicado: (2010)

Optic Neuropathy with Features Suggestive of Optic Neuritis in Cerebrotendinous Xanthomatosis
por: Miyamoto, Miyuki, et al.
Publicado: (2019)

Spinal cerebrotendinous xanthomatosis: A case report and literature review
por: Atallah, Isis, et al.
Publicado: (2021)

Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings
por: Guenzel, Adam J., et al.
Publicado: (2021)

Cerebrotendinous Xanthomatosis: A Moroccan Case Report and Review of Literature
por: Balkhadir, Hind, et al.
Publicado: (2021)

Cerebrotendinous Xanthomatosis: A practice review of pathophysiology, diagnosis, and treatment
por: Nóbrega, Paulo Ribeiro, et al.
Publicado: (2022)

Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review
por: Ribeiro, Rodrigo Mariano, et al.
Publicado: (2023)

Continuous Renal Replacement Therapy with High Flow Rate Can Effectively, Safely, and Quickly Reduce Plasma Ammonia and Leucine Levels in Children
por: Aygun, Fatih, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iv2aee9k6udtq6enoq52odffus